The first two scientific journals in the world were published by the Royal Society in England in 1665 and were the first of their kind in the world. The two journals to be published were “Philosophical Transactions of the Royal Society” and the other being “Journal des Scavants.” The published of these two journals has led to thousands of scientific periodicals being published since then with the study of medicine and biomedical sciences being published on the internet or print.Oncotarget is one of the medical journals to be descended from these two and is an open access one focusing on all aspects of oncology. The world of medical research in the biomedical science area can be one of fierce competition.
Researchers are constantly vying for sponsorship, credit for their research, and focused on making a new medical discovery. While this drive is necessary in the world of oncology and even encouraged, it has led to many researchers actively feeling competitive with their fellow researchers. Exceptional discoveries made in one lab may be unavailable to another one that could have a significant impact on research simply because of such fierce competition.Oncotarget provides a necessary platform where the open access journal has made it easier for researchers in the community to access information on oncology. The goal of Oncotarget is to have a life free of disease, but this goal can only be achieved by researchers working together.
The open access nature of oncotarget has made it easier for researchers to have access to each other’s research which can be applied to their own studies. Hopefully leading to exceptional discoveries being made in the field.The peer reviewed medical journal is also widely popular due to providing insightful, constructive, and punctual research with each of the papers published. They allow free access to the papers published which come out in online, weekly issues. Each issue of the medical journal can also be printed upon special request. The mission of the medical journal is to make research more widely available and easier to access for people in the oncology medical community.